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GermanyABSTRACT The cellular cytoskeleton is crucial for many cellular functions such as cell motility and wound healing, as well as
other processes that require shape change or force generation. Actin is one cytoskeleton component that regulates cell
mechanics. Important properties driving this regulation include the amount of actin, its level of cross-linking, and its coordination
with the activity of specific molecular motors like myosin. While studies investigating the contribution of myosin activity to cell
mechanics have been performed on cells attached to a substrate, we investigated mechanical properties of cells in suspension.
To do this, we used multiple probes for cell mechanics including a microfluidic optical stretcher, a microfluidic microcirculation
mimetic, and real-time deformability cytometry. We found that nonadherent blood cells, cells arrested in mitosis, and naturally
adherent cells brought into suspension, stiffen and become more solidlike upon myosin inhibition across multiple timescales
(milliseconds to minutes). Our results hold across several pharmacological and genetic perturbations targeting myosin. Our find-
ings suggest that myosin II activity contributes to increased whole-cell compliance and fluidity. This finding is contrary to what
has been reported for cells attached to a substrate, which stiffen via active myosin driven prestress. Our results establish the
importance of myosin II as an active component in modulating suspended cell mechanics, with a functional role distinctly
different from that for substrate-adhered cells.INTRODUCTIONThe actin polymer network in cells is responsible for many
cellular functions: it is involved in determining cell shape, in
cell migration and in generating forces (1–4). Actin forms
different types of networks in forms of branched or bundled
fibers and provides mechanical stability to cells. The latter
can be controlled by the amount of filamentous actin and
the cross-linking between these filaments (5), which are
both tightly regulated by the cell according to its functions
(1). The actin cytoskeleton is fundamentally different in
adherent cells compared to cells in suspension, mainly re-
flected in the absence of stress fibers in suspended cells.
Therefore, it is not surprising that differences in mechanical
properties can be found which reflect the different func-
tional requirements of these cells (6). It has even been
shown that adherent cells change mechanical properties
directly after they are detached from substrates and brought
into suspension (7). Apart from the filaments themselves
and their cross-linkers, there are also molecular motors,
such as myosin II, which can interact with and modify the
actin cytoskeleton (1). Molecular motors are micromachines
that can transport cargo within cells along microtubules (ki-
nesin, dynein) or slide two actin filaments along each otherSubmitted June 19, 2014, and accepted for publication March 4, 2015.
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0006-3495/15/04/1856/14 $2.00(myosin). Filament sliding is important when the cell needs
to change its shape or to exert forces, as it does during
cell migration, mitosis, (muscle) cell contraction, wound
closure, or mechanosensing of its environment. The activity
of myosin II can also influence the mechanical properties of
cells by prestressing the actin cortex underlying the plasma
membrane (8) and by generating tension along actomyosin
stress fibers (9). Adherent cells have anchoring points to
the substrate, called focal adhesions, and actin stress fibers
are spanning through the cell from one focal adhesion point
to another. Attachment to a substrate is thus a prerequisite
for the formation of stress fibers and their abundance de-
creases with the stiffness of the substrate (10).
Interestingly, the progressive disappearance of stress fi-
bers on compliant substrates correlates with a softening of
the cells, presumably due to decreasing prestress in the actin
network (10,11). This modulation of cell mechanical prop-
erties by the state of attachment needs to be taken into
account when choosing a cell mechanics measurement tech-
nique. There are several ways of measuring mechanical
properties of adherent cells. A popular method is atomic
force microscopy, which can probe viscoelastic properties
of cells with high spatial resolution by indenting the surface
of the cell with a nano- to micrometer-sized probe (7,12). A
different approach is magnetic twisting cytometry, where
magnetic beads are bound to the surface of cells and forces
are applied by external magnetic fields (13). Techniques forhttp://dx.doi.org/10.1016/j.bpj.2015.03.009
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less common. This can be done by micropipette aspiration
(14) or optical tweezers, which trap and move beads bound
to the surface of cells (15). Most of these methods have low
throughput and still require physical contact with the cell
surface, which can still induce focal adhesions and stress
fibers (16). One way of measuring pure mechanical proper-
ties of cells in absence of stress fibers is by means of a
microfluidic optical stretcher, where no physical contact is
required because forces are generated via momentum trans-
fer of light (17,18). Another measurement technique is
based on the concept of measuring advection times of cells
on passage through microchannels, which has been shown
to correlate with whole-cell compliance (6,18). Finally,
hydrodynamic stretching of cells through a microfluidic
channel allows high throughput quantification of cell defor-
mation by shear stresses and pressure gradients, and
provides an alternative technique to characterize cell de-
formability in suspension on shorter timescales (19).
Measuring cells adhered to rigid substrates and cells that
are completely in suspension represents the two extremes of
cellular attachment. In this study, we investigated the role of
myosin motors on the rheological properties of cells in sus-
pension. We focused on non-muscle myosin II, which spe-
cifically cross-links two actin filaments and exerts tension
(20). There are several drugs to interfere with myosin II ac-
tivity, such as blebbistatin, Y-27632, ML7, or phorbol
12,13-dibutyrate. Blebbistatin is a small molecule inhibitor
that selectively inhibits non-muscle myosin II in a state
where the myosin head is not attached to the actin filament
(21). Y-27632 also inhibits myosin activity but via the inhi-
bition of the Rho-associated kinase (22). ML7 directly tar-
gets the myosin light chain kinase pathway by inhibiting
its activity (23). Phorbol 12,13-dibutyrate, on the other
hand, activates the protein kinase C (24,25) and therefore in-
creases myosin II activity. So far, there exists a range of data
on mechanical property measurements of adherent cells
treated with these drugs (26–29), which have shown that in-
hibition of myosin activity leads to a loss of cell prestress
and a subsequent lower measured elastic modulus of the
cells.
Because no systematic study of the effect of these phar-
macological interventions for cells in a fully suspended state
(i.e., without physical attachment to the probe) has been
conducted (to our knowledge), we focused on studying the
effect of myosin inhibition on the mechanical compliance
of cells in suspension, using a microfluidic optical stretcher
(OS), a microfluidic microcirculation mimetic (MMM), and
a real-time deformability cytometer (RT-DC). To compare
with existing reports on adherent cells, we specifically
included studies of 3T3 fibroblasts, HeLa cells, and
TNGA mouse embryonic stem cells detached from the sub-
strate before the measurement, as well as cells in naturally
nonadherent states such as mitotic cells. To assure that the
observed effect is not specific to adherent cells, we carriedout further studies on two distinct hematopoietic cell lines,
NB4 and HL60 leukemia cells (both nonadherent cells
growing naturally in suspension), as well as HL60-differen-
tiated lineages: neutrophils, monocytes, and macrophages.
Our results showed that apart from the macrophages and
neutrophils (to a lesser extent), all the tested cell lines in sus-
pension showed a significant decrease in cell compliance
and fluidity, and a concomitant increase in steady-state vis-
cosity with myosin inhibition on a deformation timescale of
seconds, opposite to what has been reported for cells
attached to substrates. Our work provides unambiguous
evidence that myosin II plays a fundamentally different
role in modulating cell mechanical properties of suspended
cells as compared to adherent cells, possibly through
myosin-induced actin disassembly.MATERIALS AND METHODS
Microfluidic optical stretcher
The principle and setup of the microfluidic OS have been described exten-
sively elsewhere (17,18). Essentially, the device is a dual beam laser trap
capable of trapping and deforming cells through optically induced stress
acting on the cell surface. The microfluidic flow chamber consists of two
coaxial optical fibers aligned perpendicular to a square glass capillary,
which delivers the cells in suspension. The chamber was mounted on an in-
verted microscope (Eclipse TE2000U) equipped with a Plan Fluor ELWD
40 /0.60 NA objective (both from Nikon, Tokyo, Japan). A charge-
coupled device camera (AVT MARLIN F-146B, 50 frames/s; Firstsight
Vision, CA) was attached to the microscope for image acquisition. The
flow of cell suspension was adjusted through the relative difference in
heights of an inlet and outlet reservoir connected to the capillary. The
laser used was a single-mode, continuous-wave fiber laser at a wavelength
of l ¼ 1064 nm (YLM-5-1070-LP; IPG Photonics, Oxford, MA).
For imaging and data analysis, a custom-built LABVIEW software
(National Instruments, Austin, TX) was used to track the cell shape during
the stretching. Data of the cell deformation along the major axis r(t) was
stored for every time-frame, while r0 was the measured length of the cell
during the initial trapping period. The time-varying axial strain,
gðtÞ ¼ ðrðtÞ  r0Þ=r0;
was then evaluated accordingly. The optically induced stress was computed
using the generalized Lorenz-Mie model (Boyde et al. (30)). A generalstress profile modeled for a sphere is shown in Fig. S1 in the Supporting
Material. Once the peak stress so along the laser axis was evaluated, the
time-dependent creep compliance J(t) could be readily obtained as
JðtÞ ¼ gðtÞ
soFG
; (1)
where FG is a geometric factor that takes into account the cell size and stress
distribution (31). To further extract cell viscoelastic parameters, one canemploy either a power law, or a simple mechanical model incorporating
combinations of dashpots and springs (6,7,32). The equation for the po-
wer-law model is
JðtÞ ¼ Jo

t
to
b
: (2)
Here, b ¼ 0 corresponds to Hooke’s law, where the cells behave like a
perfectly elastic material, while b ¼ 1 corresponds to Newton’s law ofBiophysical Journal 108(8) 1856–1869
1858 Chan et al.viscous deformations, with the cells behaving like a fluid. The b is therefore
a measure of the cell fluidity. The prefactor Jo characterizes the compliance
of the material, while the time is normalized by a timescale to, which is set
to 1 s. Because the power-law model assumes timescale independence,
which may not generally hold for biological cells, we also fit the compli-
ance data with the standard linear liquid (SLL) model, which has been
recently shown to characterize cell deformation for blood precursor cells
(6). The creep compliance for such a model takes the form
JðtÞ ¼ 1
Et

1 eEtht t

þ 1
hs
t; (3)
where Et represents the transient elastic response within the cytoskeleton
while h represents the transient viscosity, possibly arising from the poroe-t
lastic effect (33). The value hs represents the steady-state viscosity at long
timescales, possibly originating from molecular slips between the transient
cross-linkers in the cell cortex. A transition time, t ¼ ht/Et, can also be
defined as the characteristic timescale beyond which the steady-state
viscous behavior starts to dominate.
For each cell type under different pharmacological treatment, the number
of selected cells per OS experiment was nR 30. The creep compliance data
are depicted as mean5 SE. Representative compliance data were selected
from two or more independent measurements. All measurements were per-
formed at room temperature. All plotting, statistical analysis, and curve
fitting were performed using ORIGIN 8.5 software (OriginLab, Northamp-
ton, MA) and MATLAB (The MathWorks, Natick, MA). All box plots
include whiskers at 5–95% range, horizontal box lines at 25–75% range,
median line, and the mean. For parametric fitting, the extracted rheological
parameters were computed within 95% confidence bounds using the
nonlinear least-squares regression algorithm, and presented as the best fit
values5 SE of the estimates.Microfluidic microcirculation mimetic
To validate changes in suspended cell mechanical properties free of possible
heating artifacts as in the case of OS experiments (34), we developed a mi-
crofluidic microcirculation mimetic (MMM). A MMM is a microfluidic de-
vice consisting of a long microchannel with many successive constrictions
smaller than the cell diameter. The passage of cells driven through a MMM
should be inversely correlated with the compliance of the cells because the
timescales of passing through the full device is comparable with the time-
scales of optical stretching. The production of MMMs was done using stan-
dard photolithographic techniques as reported in our previous work (6). In
short, PDMS (Sylgard 184; Dow Corning, MI) was degassed by centrifuga-
tion (1200 rpm for 20 min), poured onto molds, and baked for ~20 min at
100C. Inlet and outlet holes were punched (1.5 mm hole; Harris Uni-
Core, Sigma-Aldrich, Munich, Germany) in the PDMS chip. The chips
were bonded to 22-mm glass cover slides (No. 1; Marienfeld-Superior,
Lauda-Ko¨nigshofen, Germany) using air plasma (Plasma Cleaner PDC-
32G; Harrick Plasma, Ithaca, NY). MMMs with 5 and 7 mm as the smallest
constriction widths (maximum width 15 mm) were made with a constant
height of 15 mm. The inlet and outlet of the devices were connected to a
computerized air pressure control system (MFCS-FLEX; Fluigent, Villejuif
France) using custom-cut pipette tips (Eppendorf, Hamburg, Germany) in
which ~20–40 mL of cell suspension was introduced for each experiment.
The device was mounted on a model No. IX-70 inverted microscope with
40 objective for measuring cell size and 5  objective for measuring
the advection time through the entire device (both objectives fromOlympus,
Tokyo, Japan). A camera (DMK 21BF04; The Imaging Source, Bremen,
Germany) was used to record advection videos at a frame-rate of
60 frames/s. Advection times were extracted from the videos using
custom-made written codes in MATLAB (The MathWorks, Natick, MA).
For each cell type under different pharmacological treatment, the number
of selected cells per MMM experiment was nR 30, and the advection times
are representative of two independent experiments.Biophysical Journal 108(8) 1856–1869Real-time deformability cytometry
The basic idea of RT-DC is to quantify the deformation of cells on shorter
timescales (approximately milliseconds) by shear stresses and pressure gra-
dients while flowing through a narrowmicrofluidic channel (19). The micro-
fluidic chip is made of PDMS (Sylgard 184; VWR, Darmstadt, Germany)
using standard soft-lithography methods. After cross-linking the polymer
for 45 min at 70C and opening an inlet and outlet with a 1.5-mm biopsy
puncher (Harris Uni-Core; Sigma-Aldrich), the bottom of the chip is sealed
with a glass cover slide (thickness 2; Hecht, Pfaffenhofen an der Ilm, Ger-
many) after plasma surface activation (PDC 32-G; Harrick Plasma, Ithaca,
NY) of the PDMS. The microfluidic chip consists of two reservoirs con-
nected by a 300-mm-long narrow channel with a 20  20 mm (as for HL60
cells) or 30  30 mm square cross section (for 3T3 fibroblasts). After fabri-
cation, the chip is assembled on an Axiovert 200M inverted microscope
(Carl Zeiss, Oberkochen, Germany) and connected to a syringe pump
(NemeSyS; Cetoni, Korbussen, Germany). A high-power LED (CBT-120,
462 nm; Luminus Devices, Woburn, MA) is operated with a pulsed current
for sample illumination. Image acquisition of cells is done using a high-
speed CMOS camera (MC1362; Mikrotron, Unterschleissheim, Germany).
Cells are resuspended in a solution of PBS (phosphate-buffered saline)
and 0.5% (w/v) methylcellulose (Sigma-Aldrich) to a final concentration
of 106 cells/mL. Addition of methylcellulose helps prevent sedimentation
of the cells. The cell suspension is drawn into a 1-mL syringe connected
to the inlet of the chip. As the cell suspension is pumped through the chip,
it gets deformed from a spherical into a bulletlike shape within the channel.
An image analysis algorithm continuously analyzes the images from the
camera in real-time, detects the presence of a cell inside the region of
interest, and finds the cell contour. The quantified cell deformation (1, circu-
larity) and cell size (cross-sectional area) are then displayed as a scatter plot
and the average deformation is defined as the extracted mode (peak) of the
fitted distribution. All data acquisition is carried out at the rear part of the
300-mm-long channel where the cell shape has reached steady state. As a
reference, the deformation of the nondeformed cells in the reservoir is
also measured. In a typical experiment, ~2000 cells are analyzed at a partic-
ular flow rate, and more than three repeat experiments are performed.Cell culture and differentiation
3T3 fibroblasts and HeLa cells were cultured in DMEMmedium containing
10% FBS (fetal bovine serum) and 100 U/mL penicillin-streptomycin (all
from Life Technologies, Carlsbad, CA, Germany). The TNGA mouse em-
bryonic stem cell line was a kind gift from the lab of Austin Smith, and were
cultured in GMEM-medium (Sigma-Aldrich) supplemented with 10% FBS,
2 mM GlutaMax, 100 U/mL penicillin-streptomycin, 1 MEM nonessen-
tial amino acids, 100 mM 2-mercaptoethanol (all from Life Technologies),
1 mM sodium pyruvate (Sigma-Aldrich), and 1000 U/mL LIF (Millipore,
Billerica, MA). NB4 and HL60 cells were cultured in RPMI-1640 medium
containing 10% FBS, 2 mM L-glutamine, and 100 U/mL penicillin-strepto-
mycin (all from Life Technologies). HL60 cells were induced to differen-
tiate along the myeloid lineage following well-established protocols
(6,35). In essence, mature neutrophil- and monocyte-like cells were ob-
tained from HL60 cells 96 h after induction of differentiation. Macro-
phage-like cells were obtained 24 h after induction of differentiation. For
experiments on pharmacological interventions, cells were treated with
50 mM of blebbistatin or 10 mM of ML7 for 20 min, with 10 mM of
Y-27632 for 30 min, and 2 mM of cytochalasin D for 10 min, all before
the experiments. Jasplakinolide was added to a final concentration of
1 mM and incubated for 30 min before the experiments, while phorbol
12,13-dibutyrate was added to a final concentration of 100 nM and incu-
bated for 1 h before experiments. All pharmacological drugs were obtained
from Sigma-Aldrich unless otherwise stated.
For myosin II knock-down experiments, MYH9 siRNA plasmids
(SMARTpool ON-TARGETplus; GE Dharmacon, Lafayette, CO) or nega-
tive controls (ON-TARGETplus nontargeting Pool; GE Dharmacon) were
Myosin II Activity Softens Cells in Suspension 1859transiently transfected into 3T3 fibroblasts using the Lipofectamine2000 re-
agent (Life Technologies) following the manufacturer’s instructions. In
brief, transfections were performed in six-well plates. For each well,
2.5 mg of plasmid DNAwas added to 250 mL of Opti-MEM (Life Technol-
ogies) reduced serum medium, while a separate mixture of 5 mL
Lipofectamine2000 and 250 mL Opti-MEM was being prepared. Both mix-
tures were incubated for 5 min at room temperature before being combined
and left for another 20 min at room temperature. The entire volume was
then added to each well with cells already added with 2 mL cell medium.
The cells were incubated for another 72 h before being assayed for OS
experiments. For OS experiments on mitotic HeLa cells, cell synchroniza-
tion was achieved by a standard double thymidine (Sigma-Aldrich) block
and release protocol, and 10 mM dimethylenastron (VWR) was applied
for 10 h to keep the cells in the mitotic phase.Fluorescence imaging of suspended cells
For actin staining of cells in suspension, trypsinized cells were first washed
with prewarmed PBS, before being treated with 50 mM of blebbistatin or
10 mM of ML7 and incubated for 20 min in a cell culture incubator. The
cells were then fixed with 4% formaldehyde in PBS solution for 20 min
at room temperature. This way, the cells were ‘‘frozen’’ in the suspended
state before they had any time to start adhering to the substrate. A quantity
of 100 mL of the suspended fixed cells was then seeded onto a PLL (poly-L-
lysine)-coated glass slide for 20 min at room temperature. For permeabili-
zation, we incubated the cells with 0.1% Triton X-100 diluted in PBS for
5 min. After that, the cells were stained with phalloidin-Alexa-Fluor 488
(Life Technologies) diluted in a 1% BSA solution in PBS for a final concen-
tration of 165 nM, and incubated for 20 min at room temperature in the
dark. The sample was then washed three times with PBS. Cells stained
for actin were imaged in confocal mode using a model No. LSM 700
confocal microscope (Carl Zeiss) with a C-Apochromat 40 /1.2 NAwater
objective (Carl Zeiss). Gain settings were kept the same for all samples of a
given experiment. For statistical comparison of morphological change in
actin cortical structures between the control and blebbistatin-treated cells,
multiple images from different regions of the dish were collected in each
experiment.Ultrastructural imaging using scanning electron
microscope
Cells were washed in PBS once before being trypsinized and resuspended in
4% PFA (paraformaldehyde) in PBS. The cells were left in fixatives for
20 min at room temperature. The cells were then resuspended in PBS
and seeded onto PLL-coated cover glass. After 10 min, PBS was removed
and 1% Triton X-100 in PBS buffer was added and the permeabilization
was performed at room temperature for 5 min. The cover glass was thencreep response follows a power law, with b ¼ 0 for purely elastic materials, u
such as cells (see inset). The SLL model comprises the transient elastic (Et) a
To see this figure in color, go online.washed three times with PBS. After that, the cells were dehydrated in
a graded series of ethanol before being critical-point-dried with liquid
carbon dioxide, and sputter-coated with gold (5–10 nm in thickness). The
specimens were later examined under a scanning electron microscope
(JSM-7500F; JEOL, Eching, Germany) operated at an accelerating voltage
of 5 kV.RESULTS
Suspended adherent cells stiffen with myosin II
inhibition
To investigate changes to suspended cell mechanical proper-
ties when subjected to pharmacological interventions, an OS
was employed (Fig. 1 A) to measure the whole-cell compli-
ance in the suspended state, with or without drugs in the sus-
pension medium. As discussed in Materials and Methods,
the time-dependent strain of the cells is extracted and
normalized by the peak stress and a geometric factor to
obtain the creep compliance for the cell, as shown in
Fig. 1 B. We define the peak compliance as the compliance
at the end of the stretch period (t¼ 4 or 3 s). Suspended cells
typically respond to the optical stress in a viscoelastic
manner, with cell fluidity b ranging from 0.3 to 0.6
(32,34). A fit of the data with the SLL model allows us to
further extract meaningful viscoelastic parameters at tran-
sient and long timescales. Because the deformation response
at very small timescales can vary significantly among
different drugs and cell types, we focused on first extracting
hs, the relevant fitting parameter at long timescales. To do
this, we fit a linear function to the compliance curves for
t > 2 s. The inverse slope yields hs and the inverse intercept
Et. We subsequently fit the model to the entire data and
minimized with respect to ht to determine its value, while
keeping hs and Et fixed. We note that although the SLL
model may not render the best fits to all compliance data
for different cell lines under various treatments, which
attests to their fundamental rheological differences, we opt
to settle on the SLL model in order to drawmeaningful com-
parison of the viscoelastic parameters.
Given that adherent cells have been shown to soften with
myosin II inhibition (26–29), we seek to address theFIGURE 1 Schematic of an optical stretcher
experiment and data analysis. (A) Cells flowing
through the microfluidic channel are serially trap-
ped and stretched by two diverging, counterpropa-
gating laser beams emanating from single-mode
optical fibers. The momentum transfer of light to
the surface of the cell results in (mainly axial) opti-
cally induced surface stresses, leading to cellular
deformation along the optical axis. (B) Creep
compliance curve for a representative HL60 cell
stretched at 0.9 Pa. The creep compliance curve
can be fitted to a power-law (P) model or a SLL
mechanical model. In the power-law model, the
nity for a purely viscous fluid, and 0 < b < 1 for viscoelastic materials,
nd viscous components (ht), and the steady-state viscous component (hs).
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1860 Chan et al.following question: will the same effect be observed for
such cells when they are in a fully suspended state in the
absence of any stress fibers? As such, we detached 3T3 fi-
broblasts from the substrates using trypsin/EDTA, before
measuring their deformability in the OS. As depicted
in Fig. 2 A, the untreated 3T3 fibroblasts, when stretched
by a constant optically induced stress of 0.85 Pa, showed
a time-dependent creep compliance that appeared to in-
crease linearly with time, indicative of a fluidlike behavior.
When the cells were stretched in the presence of a myosin II
inhibitor such as blebbistatin, the entire creep compliance
curve changed significantly (Fig. 2 A, red). Specifically,
the curve consisted of an initial rapid increase in creep
compliance, followed by a gradual decrease in the rate of
compliance. In view of recent evidence of phototoxicity
and photoinactivation of blebbistatin by UV and blue light
(36,37), we tested the effect of another myosin-inhibitor,
Y-27632, and affirmed a similar change in the creep compli-
ance profile (Fig. 2 A, green). The same effect was also
observed for two additional adherent cell lines, HeLa cells
and TNGA mouse embryonic stem cells (Fig. 2, B and C),
thereby ruling out a cell-specificity issue.
Furthermore, OS measurements for HeLa cells up to 60 s
(Fig. S2) confirm that the effect of myosin II inhibition does
not reverse or become nonlinear at longer timescales. As
shown in Fig. 2 D, all three cell lines exhibited a signifi-CBA
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Biophysical Journal 108(8) 1856–1869cantly lower peak compliance for the blebbistatin or
Y-27632-treated cases than those of the controls. When
we fit the power-law model to the data, we observed a dra-
matic decrease in cell fluidity b for cells treated with bleb-
bistatin or Y-27632, indicating that the cells became more
solidlike after inhibition of myosin II activity (Fig. 2 E
and Table S1 in the Supporting Material). Further fitting
with the SLL model showed that for cells treated with bleb-
bistatin or Y-27632, there was a significant decrease in the
transition time t (Fig. 2 F; Table S2), suggesting that
the cells reached their steady-state viscous state quicker.
Furthermore, this effect is accompanied by a significant in-
crease in the steady-state viscosity hs for all cells treated
with blebbistatin or Y-27632 (Fig. 2G), indicating that these
cells flow at a much lower rate at long timescales.
To ascertain that the effect of cell stiffening is not an
experimental artifact due to photodestabilization of the
drugs during optical stretching, we also performed OS ex-
periments on myosin II knocked-down cells and control
cells. The results are depicted in Fig. 3 A. Indeed, 3T3 fibro-
blasts treated with RNAi against MYH9, the heavy chain
subunit of myosin IIA, showed a strong decrease in deform-
ability compared to the control cells, as reflected by the sig-
nificant drop in peak compliance (inset). We hypothesize
that this stiffening phenomenon may be attributed to specific
actions of myosin on actin filaments. Hence, we carried out1 2 3
Stretching time (s)
(control)
(bleb)
FIGURE 2 Influence of myosin inhibitors on the
compliance of adherent cell lines brought into
suspension. (A) Compliance of 3T3 fibroblasts
when treated with blebbistatin (n ¼ 89) or
Y-27632 (n ¼ 72), compared to controls (n ¼
65). (B and C) Compliance of blebbistatin-treated
HeLa cells (n ¼ 94) and TNGA mouse embryonic
stem cells (n ¼ 45) compared to their respective
controls (n ¼ 89, 30). (Brown and blue lines) Fits
of the power-law model and SLL model to the
compliance data, respectively. (D) Box plots of
the peak compliance for various cell lines under
blebbistatin or Y-27632 treatments. Statistical sig-
nificance is indicated by asterisks: ****p <
0.0001. (E–G) Cell fluidity, % change in transition
times, and % change in steady-state viscosity,
respectively, for various cell lines treated with
blebbistatin or Y-27632. Error bars are standard
errors of the fit parameters. To see this figure in
color, go online.
Myosin II Activity Softens Cells in Suspension 1861independent OS experiments on cells treated with Jasplaki-
nolide, an actin-stabilizing drug that promotes actin poly-
merization (Fig. 3 B). Interestingly, we found that the
compliance curve of Jasplakinolide-treated 3T3 fibroblasts
closely resembled that of the blebbistatin-treated cells,
providing hints that myosin II may play a critical role in
actin turnover dynamics on suspended cells free of any focal
adhesions or stress fibers.
Finally, as a control to confirm the structural integrity of
actin filaments in regulating such behavior, we conducted
further ‘‘no-cortex’’ controls for 3T3 cells in which cells
were treated with 2 mM cytochalasin D, which depolymer-
izes the actin cortex, before further treatment with blebbis-
tatin. We observed a significant stiffening of 3T3s treated
with blebbistatin (Fig. 3 C, red) compared to the controls
cells, confirming previous results. When cells were treated
with cytochalasin D (Fig. 3 C, blue), they were significantly
more compliant than the control cells, confirming the role of
actin in cell deformability. However, we observed no signif-
icant difference in the creep compliance profile (Fig. 3 C,
green) and the peak compliance (Fig. 3 D) between cells
treated with only cytochalasin D and those treated with
both cytochalasin D and blebbistatin. This supports our hy-
pothesis that indeed myosin inactivation-induced stiffening
is attributed to disruption of specific action of myosin on the
actin cortex. As a positive control, we also carried out OS
experiments on 3T3 fibroblasts treated with phorbol
12,13-dibutyrate, which is known to enhance myosin II ac-
tivity (Fig. S3). Here we observed just the opposite effect:
the phorbol 12,13-dibutyrate-treated cells were moreBA
DCcompliant compared to the control cells, as indicated by a
slightly higher compliance curve throughout the stretch
period (Fig. S3 A), although the increase in peak compliance
was less significant compared to the degree of cell stiffening
for blebbistatin-treated cells (Fig. S3 B).
To gain insights into the role of actin cytoskeletal struc-
tures in the observed cell stiffening effect, we imaged
F-actin in both the untreated cells and blebbistatin-treated
cells using confocal microscopy. We observed a marked sur-
face morphological difference in the cortical actin structures
between the untreated and blebbistatin-treated 3T3 fibro-
blasts (Fig. S4, A and B). Specifically, the untreated cells
showed a dense actin cortical layer underneath the plasma
membrane, usually accompanied by many blebs and spher-
ical protuberances at the cell periphery, while the blebbista-
tin-treated cells exhibited numerous microvilli projections
on the cell surface. A similar effect was observed for cells
imaged using a scanning electron microscope (Fig. S4, C
and D) and, for cells treated with ML7, a further myosin in-
hibitor (Fig. S4, E and F). This phenotypic difference was
highly reproducible and observed across the entire popula-
tion (Fig. S5).Nonadherent cell lines exhibit similar stiffening
effect with myosin II inhibition
To ensure that the observed cell stiffening effect with
myosin inhibition is not specific to normally adherent cell
lines in suspension, we also investigated the effect of bleb-
bistatin on two distinct hematopoietic cell lines, NB4FIGURE 3 Role of actin cortex in compliance of
3T3 fibroblasts brought into suspension. (A)
Compliance curves for 3T3 fibroblasts with RNAi
against MYH9 (n ¼ 114), compared to controls
(n ¼ 95). (B) Compliance curves for 3T3 fibro-
blasts after treatment with Jasplakinolide (n ¼
38), compared to controls (n ¼ 78). (Insets in A
and B) Box plots of peak compliance for control
versus knockdown or drug treatments. (C) Compli-
ance curves for 3T3 fibroblasts after treatment with
cytochalasin D only (n ¼ 45), cytochalasin D plus
blebbistatin (n ¼ 38), or with blebbistatin only
(n¼ 80), compared to controls (n¼ 60). All exper-
iments were performed on cells of the same pas-
sage on the same day. (D) Box plots of the peak
compliance for cells under various treatments as
in (C). ****p < 0.0001, **p < 0.01 and *p <
0.05. To see this figure in color, go online.
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1862 Chan et al.leukemia and HL60/S4 myeloid precursor cells, both of
which can be differentiated into other lineages. Unlike
3T3 fibroblasts, these two cell lines grow naturally in
suspension, which makes the study of myosin II
activity in modulating suspended cell stiffness even more
pertinent. As shown in Fig. 4 A, when NB4 cells were
treated with blebbistatin and stretched by a constant
stress of 0.90 Pa, we observed a significantly less com-
pliant response than that of the controls throughout the
period of stretch. A similar stiffening effect was observed
for blebbistatin-treated, undifferentiated HL60/S4 cells
(Fig. 4 B).
An interesting question arises as to whether inhibition of
myosin II activity causes a similar cell stiffening effect for
the differentiated lineages and, more specifically, whether
there is a lineage- or function-specificity of myosin II activ-
ity in modulating cell mechanical properties. To address
this question, we differentiated the HL60 cells in vitro
into neutrophils and monocytes (see Materials and Methods
for protocol), and investigated their creep behavior in
response to blebbistatin treatment under optical stretching.
The results for neutrophils and monocytes are shown in
Fig. 4, C and D. Clearly, these cells also exhibited a
significantly less compliant response when treated with
blebbistatin. Of note is the compliance curve for blebbista-
tin-treated neutrophils, which appeared to grow linearly in
time, suggestive of a more fluidlike behavior. This is in
contrast to all other cell lines that showed a gradual
decrease in the rate of compliance with time. For the sake
of completeness, we also included studies on HL60-differ-
entiated macrophages. Macrophages are tissue-resident
cells that are adherent in nature, fundamentally different
compared to neutrophils and monocytes, which are nonad-
herent. As such, the results may not be directly comparableA
DC
B
0 1 2 3 4
0
0.02
0.04
0.06
0.08
Stretching time (s)
C
om
pl
ia
nc
e 
(P
a−
1 )
Neu (control)
Neu (bleb)
P
SLL
0 1
0
0.01
0.02
0.03
0.04
0.05
Stretchin
C
om
pl
ia
nc
e 
(P
a−
1 )
HL60 (control)
HL60 (bleb)
P
SLL
0 1
0
0.02
0.04
0.06
Stretchin
C
om
pl
ia
nc
e 
(P
a−
1 )
Mono (control)
Mono (bleb)
P
SLL
0 1 2 3 4
0
0.01
0.02
0.03
0.04
Stretching time (s)
C
om
pl
ia
nc
e 
(P
a−
1 )
NB4 (control)
NB4 (bleb)
P
SLL
Biophysical Journal 108(8) 1856–1869to that of neutrophils and monocytes. As shown in Fig. S6,
we observed that blebbistatin-treated macrophages showed
little, if any, changes in the compliance curve, as compared
to the control case.
A quantitative analysis of the creep compliance curves is
shown in Fig. 5. For NB4 cells, undifferentiated HL60 cells,
and neutrophils, the peak compliance for the blebbistatin-
treated cases was significantly lower than those of the con-
trols (p < 0.0001), while for monocytes we observed a less,
albeit still significant difference between both cases (p <
0.001) (Fig. 5 A). A comparison of the extracted power-
law exponents before and after blebbistatin treatment is
depicted in Fig. 5 B. Apart from the HL60-derived neutro-
phils, which seem to have become more fluidlike, all cell
lines exhibit a drop in the cell fluidity b after treatment
with blebbistatin, with the effect on monocytes being the
most significant (see also Table S3). This is consistent
with the previous observation of suspended 3T3 fibroblasts
becoming more solidlike or elastic after blebbistatin treat-
ment. A similar trend of solidification was observed using
the SLL model. As shown in Fig. 5 C and Table S4, there
is a general decrease in the transition time for all cases,
again with the exception of neutrophils. More importantly,
we observed a marked increase in the steady-state viscosity
hs after blebbistatin treatment for all cell lines (Fig. 5 D;
Table S4), again similar to our observation for adherent
cell lines brought into suspension.
Of note, confocal imaging of suspended HL60 cells
stained for actin revealed vast numbers of branched micro-
villi at the cell surface, compared to the controls that
displayed more surface blebs at the cell periphery (data
not shown), similar to what was observed for the 3T3
fibroblasts. This suggests that the formation of a more fila-
mentous, microvillus actin cytoskeleton with blebbistatin2 3 4
g time (s)
2 3 4
g time (s)
FIGURE 4 Influence of blebbistatin on the
compliance of naturally suspended cells. Compli-
ance of (A) NB4 cells (n ¼ 44), (B) HL60 cells
(n ¼ 94), (C) HL60-derived neutrophils (n ¼ 73),
and (D) HL60-derived monocytes (n ¼ 72),
compared to their respective controls (n ¼ 165,
89, 75, 85). (Brown and blue lines) Fits of the
power-law model and SLL model to the compli-
ance data, respectively. To see this figure in color,
go online.
DC
BA
FIGURE 5 Changes in viscoelastic parameters
of naturally suspended cells after myosin inhibition
by blebbistatin. (A) Box plots of the peak compli-
ance for various cell lines. For all cell lines tested,
the peak compliance for blebbistatin-treated cases
was significantly lower than for controls.
****p < 0.0001 and ***p < 0.001. (B–D) Cell
fluidity, % change in transition times, and %
change in steady-state viscosity, respectively, for
various cell lines treated with blebbistatin
compared to their controls. Error bars are standard
errors of the fit parameters. To see this figure in
color, go online.
Myosin II Activity Softens Cells in Suspension 1863treatment likely contributes to a stiffer actin cortex and a
reduced whole-cell compliance.Cell stiffening correlates with longer advection
time through microconstrictions
Owing to the fact that the OS, operated at a wavelength of
1064 nm, might introduce additional heating effects that
can impact cell rheology (34,38,39), we employed a
MMM to confirm the impact of changes to suspended cell
mechanical properties free from heating artifacts (see Mate-
rials and Methods). In this setup, cells were advected
sequentially through a long microchannel with many con-
strictions smaller than the cell diameter using driving pres-
sures within physiological range (50 mbar) (Fig. 6 A and
Movie S1 in the Supporting Material). We hypothesize
that because cell compliance may be the main limiting fac-tor controlling the rapid passage of cells through narrow
constrictions (6), cells treated with blebbistatin, being
stiffer, will take longer to pass through the device. Indeed,
we found that blebbistatin-treated HL60 cells required a
longer average advection time than the control cells
(Fig. 6 B), when advected through the MMM with 5-mm
wide constrictions. To test the opposite effect to the
measured cell stiffening, we treated HL60 cells with 1 mM
cytochalasin D, a drug that inhibits actin polymerization
and which has previously been shown to soften the cells
significantly (6). This led to a highly significant decrease
in the advection time, as expected because cell softening
should facilitate the passage of cells through the narrow
constrictions. In the case of 3T3 fibroblasts, we found
that most untreated cells flowed through the MMM (5 mm
constriction width) with no hindrance, but a majority of cells
treated with blebbistatin and Y-27632 were trapped even atFIGURE 6 Stiffening of blebbistatin-treated
HL60 cells in MMM. (A) Phase contrast image
of an MMM consisting of a large number of micro-
constrictions. A constant pressure difference,
maintained between the inlet and the outlet, is
used to advect cells through the device. The mini-
mum gaps at the constrictions (5 mm) are smaller
than the diameter of cells, ensuring that each cell
is sequentially deformed during the advection.
The driving pressure used was 50 mbar. Scale bar
is 15 mm. (B) Box plots of the advection time
(from entry to exit) for HL60 cells treated with
blebbistatin or cytochalasin D, as compared to con-
trols. ****p < 0.0001 and ***p < 0.001. To see
this figure in color, go online.
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1864 Chan et al.the first constriction (data not shown). We then replaced
the MMM with 7-mm constriction widths. In this case,
cells previously trapped at the first constriction were
able to passage through the first constriction, before
eventually being trapped between the fifth and the 10th
constriction. We therefore conclude that the blebbistatin-
treated 3T3 fibroblasts became considerably stiffer, similar
to the observed cell stiffening seen in HL60s. Our results
from MMM measurements support the findings from OS
measurements, and unambiguously confirm that cells,
once in suspension, stiffen with inhibition of myosin II
activity.Hydrodynamic stretching of cells at millisecond
timescales
To test the effect of myosin inhibition on cellular deform-
ability at shorter timescales than probed in the OS and
MMM, we used a technique based on the concept of
hydrodynamic stretching. Unlike the OS and MMM, which
measure cell mechanical properties with throughput rates
of 100–1000 cells/h, RT-DC offers a much higher
throughput of ~100 cells/s 19. As shown in Fig. 7 A
(also see Materials and Methods), a cell suspension is
pumped through a microfluidic chip illuminated with a
pulsed LED. Due to shear stress, a flowing cell is typically
deformed into a bulletlike shape within the channel. An
image analysis algorithm then captures and analyzes the
cell contour continuously in real-time (shown as redBiophysical Journal 108(8) 1856–1869outline over the cell). The quantified cell deformation
and cell size are then displayed as a scatter plot, with
histograms plotted, which allows us to extract the average
deformation at a particular flow rate. We measured the
changes in the average cell deformation (from the reservoir
to the microchannel) for the drug-treated cells, and normal-
ized this value to that of the control cells. The obtained
ratio is then defined as the relative deformation that
essentially gives a good measure of the cell deformability
of the drug-treated cells compared to that of the control
cells.
At these short deformation timescales in the range of
milliseconds, we observed that 3T3 fibroblasts with RNAi
against MYH9 were deformed significantly less than the
control cells (Fig. 7 B), with a relative deformation of
0.454 indicating cell stiffening associated with myosin
inactivation. As a further check, we used another pharma-
cological inhibitor of myosin, ML7, which specifically
blocks the activity of myosin light chain kinase, and
measured its effect on HL60 cell stiffness using both the
OS and the RT-DC. Similar to the results of blebbistatin-
treated cells in OS experiments, the ML7-treated cells
showed a significant decrease in cell deformability as
shown by the change in the creep compliance profile and
peak compliance (Fig. S7, A and B). RT-DC experiments
also revealed >30% decrease in cell deformability for
ML7-treated cells compared to the controls (Fig. 7 C),
consistent with the OS results. In both the genetic
knockdown and ML7 treatment experiments, the observedFIGURE 7 Hydrodynamic stretching technique
measures cell stiffness on short timescales of mil-
liseconds. (A) Schematic illustration of measure-
ment principle. A cell suspension is pumped
through a microfluidic chip with a narrow constric-
tion (see inset for top-view) using a computer-
controlled syringe pump. The cell deforms inside
the channel and imaged, and the contour (red) is
determined by image analysis algorithm in real-
time. A scatter plot of cell size versus deformation
is then obtained (each dot representing a single-cell
event). (B and C) Comparisons of the relative
deformation of control cells versus 3T3 cells with
RNAi against MYH9, and ML7-treated HL60
cells, respectively. The flow rates are indicated in
the plots. ****p < 0.0001. To see this figure in
color, go online.
Myosin II Activity Softens Cells in Suspension 1865cell-stiffening effect was reproducible over three repeat
experiments.DISCUSSION
In this study, we measured and characterized the effects of
pharmacological inhibitions or genetic knockdown, target-
ing myosin II activity on the deformability of suspended
cells, using an optical stretcher, a microfluidic microcircula-
tion mimetic, and real-time deformability cytometry. We
showed that cells, be it adherent cells brought into suspen-
sion or nonadherent cell lines growing naturally in suspen-
sion, exhibit a drop in cell compliance measured on a
seconds-timescale after the inhibition of myosin II activity.
By fitting a power law and a SLL model to the cell compli-
ance curves, we found that in general, suspended cells
became more solidlike with a concomitant increase in
steady-state viscosity after inhibition of myosin activity.
We have verified that the results were not too sensitive to
the choice of the fitting range. To do this, the compliance
curves were fitted with a linear function for t > tc, where
tc is the critical time to be tested. To test the sensitivity of
our findings on tc, we performed the full analysis for
different times between 0.8 s and 2.5 s. Fig. S8 shows hs
scaled by its average, as a function of tc. For most cell lines
and drugs tested, hs changes by<10% for 1.1 s< tc < 2.2 s.
Most of our compliance data ranges from 0 to 4 s. We thus
choose half of the maximum time, 2 s, as the critical time,
knowing that our results depend weakly on the choice
of tc. Complementary studies using MMM, which also
measures mechanical properties in their suspended state,
showed similar evidence of cell stiffening for blebbistatin-
treated cells compared to the corresponding controls
(Fig. 6). The timescale of mechanical testing in OS is be-
tween 0.1 and 10 s, while in MMM it lies between 0.01 s,
the estimated passage time of a single constriction, and
4 s, the estimated time of passing through the entire device.
In this sense, the timescales are overlapping and the results
can be compared.
A possible explanation for the change in overall cell de-
formability after myosin II inhibition is that the actin cortex
of suspended cells behaves more like a polymer melt or gel.
In this case, active myosin motors can help disentangle the
actin filaments by actively pushing the actin filaments along
each other, effectively dissipating stress that results in a
more viscous deformation response. Such a mechanism
has been demonstrated in purified actin gels mixed with
myosin (40). In this study, the gel only flowed out of an
angled cuvette after myosin being activated via ATP, thus
fluidizing the actin gel. In particular, it was reported that
such fluidlike response only occurs at timescales >8 s,
consistent with our observed changes in viscous behavior
at timescales of seconds up to one minute (Fig. S2). Further,
the gel exhibited a much shorter relaxation time and lower
viscosity after myosin activation, consistent with our obser-vation of a lower whole-cell viscosity for control cells. This
hypothesis of fluidization was further confirmed by actin
gliding assays where the speed of single actin filaments
in vitro was monitored. This speed decreased significantly
after the addition of blebbistatin (41). In the same work,
Medeiros et al. (41) further showed that actin filaments asso-
ciated with filopodia in neuronal growth cones became
longer and thicker after the addition of blebbistatin. Such
an effect could be related to a decreased rate in actin bundle
severing after myosin II inhibition. However, it is not known
if similar processes take place in suspended cells.
However, RT-DC results indicate that a decrease in cell
deformability after myosin inhibition (Fig. 7) can be de-
tected even at very short deformation timescales of millisec-
onds, suggesting that the myosin-inactivated cells are
structurally stiffer even before being deformed. A simple
estimate of myosin dynamics might help elucidate this phe-
nomenon. The speed of actin in in vitro assays has been esti-
mated to be ~5 mm/s (42), which is higher than what it will
likely be in a cell. The deformation timescale in RT-DC is in
the range of milliseconds, so during this time a myosin
motor would only walk ~50 nm (corresponding to ~18 sub-
units), which is not enough to generate sufficient force on
actin filaments and cause significant disentanglement in an
actin gel at densities and mesh sizes found in the actin cor-
tex. This finding argues against myosin-induced actin fluid-
ization as the main mechanism for cell stiffening upon
myosin inhibition. We therefore propose an alternative
mechanism based on myosin-induced actin depolymeriza-
tion, inspired by recent experiments that demonstrated the
role of myosin II in active disassembly of actin filaments
(43–45). In these publications, actin depolymerization was
attributed to an increased bending of actin fibers by active
myosin motors. Hence, a decrease in myosin activity due
to blebbistatin would result in less actin depolymerization
compared to the control cells. Because F-actin is a main
contributor to cell elasticity (17,31), this would result in
stiffer cells. Of note is the recent work by Vogel et al.
(46), which reported the direct observation of buckling
and breaking of membrane-bound actin filaments by myosin
motors using total internal reflection fluorescence micro-
scopy. Such a mechanism of filament fragmentation by
myosin may contribute to actin turnover and possibly a
lower cortex elasticity, and hence a higher whole-cell
compliance.
Our hypothesis of myosin-induced actin depolymeriza-
tion is further supported by the observation of a general
decrease in compliance for 3T3 fibroblasts treated with Jas-
plakinolide, which stabilizes actin filaments (Fig. 3 B). The
striking resemblance in compliance curves between the Jas-
plakinolide-treated cells and those treated with blebbistatin
(Fig. 2 A) points toward the picture that disabling myosin
activity leads to an effective F-actin stabilization. Our obser-
vations are consistent with previous reports showing F-actin
disassembly upon stimulation of myosin II phosphorylationBiophysical Journal 108(8) 1856–1869
1866 Chan et al.in fish keratocytes (47), and the stabilization of an equatorial
actin network during late cytokinesis arising from decreased
F-actin turnover dynamics due to blebbistatin treatment
(48). Finally, according to the reptation model (40,49), the
time for an actin filament in an entangled actin solution to
disengage from its tube confinement scales as L3 where L
is the actin filament length. Hence, if myosin participates
in active actin depolymerization, it will presumably lead
to a decrease in L and allow the actin filaments to escape
out of the confined tube more easily. The overall result is
a lower viscosity of the actin network at long timescales.
Further insights came from fluorescence imaging of the
actin cytoskeleton in suspended cells under different phar-
macological treatments. As shown in Fig. S3, cells treated
with blebbistatin and ML7 tend to exhibit a microvillus
cell surface and even thick bundles of actin filaments, while
the untreated cells displayed a blebbing surface morphology
and a more homogeneous, isotropic actin cortical layer un-
derneath the plasma membrane. Here we note that the
measured higher compliance of untreated cells are not arti-
facts due to edge detection of a more bleblike cell mem-
brane, because the same effect of cell stiffening has been
confirmed with MMM, which does not require the detection
of a cell edge and is thus insensitive to this aspect. Our ob-
servations echo findings by Maloney et al. (7) that showed a
clear correlation between effective stiffening of human
mesenchymal stem cells after prolonged suspension and a
significant reduction of blebbing cells. Furthermore, reports
by Blaser et al. (50) showed that a transient increase in
myosin activity could lead to increased separation of the
acto-myosin cortex from the plasma membrane and the sub-
sequent formation of blebs, while the opposite case of a low
myosin II level has been shown to inhibit blebbing and
increases filopodia/lamellipodia formation in amoeboid
movement (51). However, the exact molecular-scale interac-
tions between myosin II and the plasma membrane-cortex
structure remains poorly understood, as summarized by a
recent review (52). Several regulatory proteins have been
found to function as membrane-to-cortex attachment, such
as the ezrin/radixin/moesin proteins and Arp2/3 (53). It
has been found that reducing these membrane-to-cortex
attachment proteins could lead to an increase in the forma-
tion of blebs (54,55). Future works might involve the spe-
cific knockout of ezrin/radixin/moesin or Arp2/3 proteins,
and measure any corresponding changes in cell stiffness
due to such weaker coupling of the membrane to cortex.
Taken together, our results suggest that after blebbistatin
treatment, suspended cells may undergo cytoskeletal remod-
eling involving the reattachment and strengthening of
cortex-membrane links, which might also contribute to
cell stiffening.
Our observation of cell stiffening for myosin-inhibited
cells deformed at timescales of seconds stands in clear
contrast to data published on cells adherent to a substrate
(26–29). In these publications, the cells were reported toBiophysical Journal 108(8) 1856–1869soften upon myosin inhibition. Martens and Radmacher
(27) attributed this result to the cellular prestress that occurs
when myosin pulls on the actin stress fibers. Reducing the
activity of myosin therefore decreases this prestress and
the cells become more compliant and more fluidlike. The
opposite effect has also been observed for studies using
phorbol 12,13-dibutyrate to activate myosin II activity.
Moy et al. (26) applied magnetic twisting rheology to
adherent cells and found an increase in cell stiffness, also
possibly attributed to the buildup of cellular prestress. In
our study, all cell types tested (with the exception of macro-
phages) became less compliant and less fluidlike after inhi-
bition of myosin II, and vice versa. Because all our
measurements are carried out while the cells are in suspen-
sion, no focal adhesions and therefore no stress fibers are
present during the measurements. Due to the nonexistence
of these cellular structures, myosin could not exert the
same effect of prestress on cells in suspension as in adherent
cells. Hence, it stands to reason that cells in our measure-
ments do not display a greater compliance after myosin in-
hibition. Such hypothesis is supported by the work of Rico
et al. (56), who varied the adherence of cells by changing the
ambient temperature and measured cell compliance using
atomic force microscopy. They reported an increase in cell
compliance with the loss of adhesion, which is highly con-
nected to the loss of stress fibers in less adherent cells.
Notably, even when two beads were attached to otherwise
suspended 3T3 fibroblasts so that their mechanical proper-
ties could be measured using optical tweezers, the effect
of blebbistatin was cell softening, just as with cells attached
to a substrate (57). This suggests that even if the cells are in
suspension, as long as they remain connected to the environ-
ment via focal adhesions, the dominant role of myosin II
seems to be cell stiffening.
The lack of a change in cell compliance and cell fluidity
for macrophages upon myosin inhibition (Fig. S6) has been
reported in previous studies using magnetic twisting cytom-
etry (58). This effect is not likely due to a low expression
level of myosin IIA in macrophages (59,60). Instead, the
different expression levels of nesprin 1 and 2, SUN1, vimen-
tin, plectin, and lamin A/C in macrophages compared to
neutrophils and monocytes (61,62), as well as a more
adherent nature of macrophages that reside normally in
the tissue, might play a role. Alternatively, the concentration
of blebbistatin used in this study was too low to impact
myosin activity in macrophages.
There are several reports on the study of myosin activity
on the mechanical properties of cells in a suspended state
confined by specific boundary conditions. Using micropi-
pette aspiration, Tinevez et al. (63) showed that myosin in-
hibition using blebbistatin and Y-27632 can lead to a
decrease in cortical tension. A decrease in cortical tension
does not necessarily equate with a decrease in cortex stiff-
ness, because the latter also depends inversely on the cell
radius (64,65), which was not explicitly addressed in the
Myosin II Activity Softens Cells in Suspension 1867work of Tinevez et al. (63). Using an electromechanical
deformation technique, MacQueen et al. (66) found a linear
dependence of the cell stiffness (Young’s modulus) and the
cortical actin thickness. Although their setup allows charac-
terization of cell stiffness in a fully suspended state free of
any attachment to the experimental probe (similar to OS),
they did not explicitly investigate the effects of myosin II ac-
tivity on cell stiffness. Interestingly, the correlation between
cortical tension and the steady-state viscosity of neutrophils
has been studied by Tsai et al. (67) using a micropipette
aspiration technique. Their work showed that with the addi-
tion of cytochalasin B, which induces actin depolymeriza-
tion, both the cortical tension and the steady-state
viscosity drop, consistent with our results on cell softening
with cytochalasin D treatments (Fig. 3 C).
In the context of development, there are several cell sys-
tems where actomyosin can exist primarily as cortices
without stress fibers or focal adhesions. Examples of these
include embryonic progenitor cells, egg cells, and meiotic
cells. Another closely related system is a cell undergoing
mitosis. During this process, a global increase of myosin
activity results in an increase in cortical stiffness and the
dissolution of focal adhesions, leading to cell rounding
(4,64,65,68). Extrapolating these results would mean that
a decrease of myosin activity results in an effective decrease
of cell stiffness, an effect contrary to our data. However, the
exact effects of myosin inhibition on mitotic cells are less
studied. A recent study shows that mitotic HeLa cells
become more compliant when myosin II activity is inhibited
with the knockdown of Ect2, a central regulator of mitotic
rounding (69). This result is contrary to our presented find-
ings. To clarify the apparent discrepancy, we carried out OS
experiments on arrested mitotic HeLa cells with and without
blebbistatin treatment, as shown in Fig. S9. We observed the
mitotic cells to be stiffer than the interphase cells, consistent
with previous work (4,69). Surprisingly, the addition of
blebbistatin to mitotic cells led to a further increase in cell
stiffness, confirming our main finding that myosin inhibition
leads to cell stiffening as long as the cells are in a suspended,
nonattached state. This also suggests that the effect of Ect2
inhibition and blebbistatin treatment are not equivalent or
comparable, possibly due to the fact that Ect2 inhibition
does lower the amount of F-actin and decreases the activity
of myosin II, both of which exert opposite effects on cell
stiffness. As such, it is plausible that the effect of a lower
amount of F-actin dominates the effect of reduced myosin
activity, leading to an overall increase in cell deformability
in this particular case.
Apart from its specific actions on the cortical actin struc-
tures, myosin II activity can also exert secondary effects on
other cellular structures. For example, recent work has
shown that molecular motor activity can lead to constant
agitation of cytoplasm (70), which may influence the assem-
bly of cytoskeletal architecture, although the direct influ-
ence of myosin motors in enhancing the fluctuations ofactin filaments has not been shown empirically. Further-
more, there is recent evidence for cytoskeletal motors and
cross-linking proteins synergistically sharing the force
applied to the cell cortex (71). Notably, in the absence of
myosin II, a-actinin cross-linkers can accumulate at the sites
of highest dilation of the cortex to counteract the applied
force. Therefore, it is conceivable that inhibiting myosin ac-
tivity may lead to an increased binding rate of these cross-
linkers, which results in a form of compensation effect
and increased cell stiffness.
In summary, cells, once suspended and free from any
physical attachment to the surrounding, stiffen and become
more solidlike after myosin II inhibition—contrary to re-
ports of cell softening with adherent cells (26–29). Measure-
ments on adherent cells are generally done on cells adhering
to plastic tissue culture dishes. In living tissue, there is no
stiff material such as plastic or glass to which cells adhere.
Nonetheless, the other extreme—cells being entirely in sus-
pension as in our study—is not the normal case either. Only
specific cell types, such as nonactivated blood cells, entirely
lack attachments. For most cell types, however, the in vivo
environment is situated in between these two extremes.
Cells growing in a compliant, three-dimensional environ-
ment display fewer focal adhesions compared to cells grown
on stiff substrates (10). The increased number of focal adhe-
sions in cells on rigid substrates caused more and stronger
stress fibers (10), which then lead to an increase in cellular
prestress. Therefore, the stiffness of the cell environment
and the adhesion to that substrate need to be considered
when extrapolating to in vivo situations from cell mechani-
cal measurements carried out in vitro. The most realistic re-
sults would be obtained by measuring the effect of myosin II
inhibition on cells in their in vivo environment. However,
such a measurement is not feasible with any technique, as
of this writing, known to be available.CONCLUSION
To conclude, we find that myosin II inhibition unequivocally
leads to a significant decrease in whole-cell compliance and
a more solidlike behavior for cells in suspension at a time-
scale of milliseconds to 1 min, irrespective of whether
they are normally adhered to a substrate or naturally in sus-
pension. We have confirmed our findings with a number of
cell lines and myosin inhibitors, using a number of cell
mechanical measurement techniques such as the OS,
MMM, and RT-DC. Our work highlights the fundamentally
different role that myosin II plays in modulating mechanical
properties of suspended cells devoid of any stress fibers or
focal adhesions, as compared to cells adhered to a substrate.
In particular we have identified fingerprints of myosin-regu-
lated actin depolymerization and active remodeling of the
membrane-cortex attachment. Our work also suggests the
use of myosin II activity as a potential pharmacological
target for impacting cellular advective function of immuneBiophysical Journal 108(8) 1856–1869
1868 Chan et al.cells. This may have wide medical implications such as in
treatments of circulatory disorders.SUPPORTING MATERIAL
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